Published in Mol Cell Biol on May 01, 1983
Complete nucleotide sequence of a functional HLA-DP beta gene and the region between the DP beta 1 and DP alpha 1 genes: comparison of the 5' ends of HLA class II genes. Nucleic Acids Res (1985) 1.76
Differential expression of porcine major histocompatibility DNA sequences introduced into mouse L cells. Mol Cell Biol (1983) 0.78
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70
Nucleotide sequence of the rightward operator of phage lambda. Proc Natl Acad Sci U S A (1975) 56.75
Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci U S A (1977) 41.76
The isolation of structural genes from libraries of eucaryotic DNA. Cell (1978) 37.13
Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem (1980) 26.55
Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene (1979) 25.53
MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol (1979) 15.58
Plasmids of Escherichia coli as cloning vectors. Methods Enzymol (1979) 11.41
Analysis of repeating DNA sequences by reassociation. Methods Enzymol (1974) 10.63
Ubiquitous, interspersed repeated sequences in mammalian genomes. Proc Natl Acad Sci U S A (1980) 9.48
Elution of DNA from agarose gels after electrophoresis. Methods Enzymol (1979) 8.36
Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer. Proc Natl Acad Sci U S A (1981) 6.03
A ubiquitous family of repeated DNA sequences in the human genome. J Mol Biol (1979) 5.67
Regulation of gene expression: possible role of repetitive sequences. Science (1979) 5.34
The nucleotide sequence of the ubiquitous repetitive DNA sequence B1 complementary to the most abundant class of mouse fold-back RNA. Nucleic Acids Res (1980) 4.99
Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. Cell (1981) 4.95
The major histocompatibility complex of the mouse. Science (1979) 4.76
Clusters of genes encoding mouse transplantation antigens. Cell (1982) 4.71
SINEs and LINEs: highly repeated short and long interspersed sequences in mammalian genomes. Cell (1982) 4.25
Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. Proc Natl Acad Sci U S A (1982) 3.73
Organization of the constant-region gene family of the mouse immunoglobulin heavy chain. Cell (1982) 3.72
Exon/intron organization and complete nucleotide sequence of an HLA gene. Proc Natl Acad Sci U S A (1982) 3.72
Molecular cloning of a human histocompatibility antigen cDNA fragment. Proc Natl Acad Sci U S A (1980) 2.99
Primary structural: analysis of the transplantation antigens of the murine H-2 major histocompatibility complex. Annu Rev Biochem (1981) 2.93
Complete amino acid sequence of a papain-solubilized human histocompatibility antigen, HLA-B7. 2. Sequence determination and search for homologies. Biochemistry (1979) 2.71
Primary structure of a murine transplantation antigen. Nature (1981) 2.42
The organization of repetitive sequences in a cluster of rabbit beta-like globin genes. Cell (1980) 2.37
The clustered and scrambled arrangement of moderately repetitive elements in Drosophila DNA. Cell (1979) 2.06
Tissue-specific expression of an unusual H-2 (class I)-related gene. Proc Natl Acad Sci U S A (1982) 1.76
The protein products of the murine 17th chromosome: genetics and structure. Adv Immunol (1978) 1.76
Mouse rDNA nontranscribed spacer sequences are found flanking immunoglobulin CH genes and elsewhere throughout the genome. Cell (1980) 1.74
A chicken middle-repetitive DNA sequence which shares homology with mammalian ubiquitous repeats. Nucleic Acids Res (1981) 1.70
Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. Nature (1982) 1.48
Cloning of V region fragments from mouse liver DNA and localization of repetitive DNA sequences in the vicinity of immunoglobulin gene segments. Nucleic Acids Res (1980) 1.29
Locations of three repetitive sequence families found in BALB/c adult beta-globin clones. Nucleic Acids Res (1981) 1.15
HLA--a central immunological agency of man. Adv Hum Genet (1980) 1.15
Reiteration frequency mapping: analysis of repetitive sequence organization within cloned DNA fragments containing the human initiator methionine tRNA gene. Proc Natl Acad Sci U S A (1980) 1.13
Characterization of a porcine genomic clone encoding a major histocompatibility antigen: expression in mouse L cells. Proc Natl Acad Sci U S A (1982) 1.12
Complete amino acid sequence of pooled papain-solubilized HLA-A, -B, and -C antigens: relatedness to immunoglobulins and internal homologies. Proc Natl Acad Sci U S A (1980) 1.06
Unusual organization of DNA sequences in the chicken. Biochemistry (1978) 0.97
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37
Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03
Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A (1989) 5.10
The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A (1974) 3.92
Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med (1974) 3.64
Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol (1996) 3.01
The two-component, ATP-dependent Clp protease of Escherichia coli. Purification, cloning, and mutational analysis of the ATP-binding component. J Biol Chem (1988) 2.95
Sequence and structure of Clp P, the proteolytic component of the ATP-dependent Clp protease of Escherichia coli. J Biol Chem (1990) 2.71
Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36
VH genes encoding the immune response to beta-(1,6)-galactan: somatic mutation in IgM molecules. EMBO J (1984) 1.98
Arrangement of a highly repeated DNA sequence in the genome and chromatin of the African green monkey. J Biol Chem (1979) 1.97
The galactan-binding immunoglobulin Fab J539: an X-ray diffraction study at 2.6-A resolution. Proteins (1986) 1.96
Immunoglobulin structure: amino terminal sequences of mouse myeloma proteins that bind phosphorylcholine. Science (1974) 1.94
Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Mol Immunol (1982) 1.93
Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions. Proc Natl Acad Sci U S A (1979) 1.89
Detection of antigens specific for B-lymphoid cultured cell lines with human alloantisera. J Exp Med (1975) 1.76
Monoclonal antibodies to DNA and RNA from NZB/NZW F1 mice: antigenic specificities and NH2 terminal amino acid sequences. J Immunol (1984) 1.69
Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science (1993) 1.68
Structural basis for the specificity of phosphorylcholine-binding immunoglobulins. Immunochemistry (1976) 1.63
Nucleic acid and protein sequences of phosphocholine-binding light chains. J Exp Med (1981) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Structure at 4.5 A resolution of a phosphorylcholine-binding fab. Nat New Biol (1973) 1.60
Somatic diversification of immunoglobulins. Proc Natl Acad Sci U S A (1984) 1.59
Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immunol (1987) 1.55
Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med (1995) 1.49
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A (1999) 1.48
Gluteal necrotizing myofascitis: an unusual delayed complication of abdominal sacrocolpopexy. Am J Obstet Gynecol (2001) 1.47
Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A (1982) 1.46
Spectral changes on binding of oligosaccharides to murine immunoglobulin A myeloma proteins. Biochemistry (1973) 1.45
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol (1989) 1.41
Somatic mutation in a cultured mouse myeloma cell affects antigen binding. Proc Natl Acad Sci U S A (1982) 1.39
Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma. Hum Gene Ther (1998) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Neonatal care in northeast Zaire. J Obstet Gynecol Neonatal Nurs (1992) 1.38
Structural requirements for the binding of derivatives of D-galactose to two homogeneous murine immunoglobulins. Biochemistry (1974) 1.38
HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. Proc Natl Acad Sci U S A (1998) 1.36
Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis. Proc Natl Acad Sci U S A (1972) 1.34
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol (2000) 1.34
Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene. Mol Cell Biol (1988) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Structure and expression of two porcine genomic clones encoding class I MHC antigens. J Immunol (1985) 1.32
Variable region sequence of the heavy chain from a phosphorylcholine binding myeloma protein. Biochemistry (1974) 1.31
Galactan-binding antibodies. Diversity and structure of idiotypes. J Exp Med (1983) 1.30
Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins. Proc Natl Acad Sci U S A (1976) 1.27
Novel post-translational regulation of TCR expression in CD4+CD8+ thymocytes influenced by CD4. Nature (1990) 1.24
Polymorphism in immunoglobulin heavy chains suggesting gene conversion. Proc Natl Acad Sci U S A (1982) 1.24
Purification and properties of Gal repressor:pL-galR fusion in pKC31 plasmid vector. J Biol Chem (1987) 1.23
Six BALB-c IgA myeloma proteins that bind beta-(1-6)-D-galactan. Partial amino acid sequences and idiotypes. J Exp Med (1973) 1.22
A spontaneously arising mutation in the DLAARN motif of murine ZAP-70 abrogates kinase activity and arrests thymocyte development. Immunity (1997) 1.22
Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother (2003) 1.22
Polymorphism in anti-phosphocholine antibodies reflecting evolution of immunoglobulin families. J Exp Med (1983) 1.21
T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells. J Immunol (1989) 1.20
Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250. Mol Cell (2001) 1.20
Studies on the interaction of H1 histone with superhelical DNA: characterization of the recognition and binding regions of H1 histones. Nucleic Acids Res (1976) 1.19
Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood (2000) 1.17
k Chain variable regions from three galactan binding myeloma proteins. Biochemistry (1978) 1.17
TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. Proc Natl Acad Sci U S A (2001) 1.15
Metronidazole-resistant vaginal trichomoniasis--an emerging problem. N Engl J Med (1999) 1.13
kappa Chain joining segments and structural diversity of antibody combining sites. Proc Natl Acad Sci U S A (1980) 1.13
A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology (1999) 1.13
Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science (1993) 1.13
Immunoglobulin structure--function correlates: antigen binding and idiotypes. Contemp Top Mol Immunol (1983) 1.12
Expression of a microinjected porcine class I major histocompatibility complex gene in transgenic mice. Science (1985) 1.12
Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci U S A (1998) 1.12
Characterization of a porcine genomic clone encoding a major histocompatibility antigen: expression in mouse L cells. Proc Natl Acad Sci U S A (1982) 1.12
Second genetic locus in the HLA region for human B-cell alloantigens. Nature (1976) 1.11
A complex regulatory DNA element associated with a major histocompatibility complex class I gene consists of both a silencer and an enhancer. Mol Cell Biol (1991) 1.10
H5 Histone and DNA-relaxing enzyme of chicken erythrocytes. Interaction with superhelical DNA. J Biol Chem (1976) 1.09
Distribution of mRNAs coding for liver and heart gap junction proteins in the rat central nervous system. J Comp Neurol (1991) 1.08
kappa Chain variable region from M167, a phosphorylcholine binding myeloma protein. Biochemistry (1978) 1.07
Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol (2001) 1.07
Sequence variation among heavy chains from inulin-binding myeloma proteins. Proc Natl Acad Sci U S A (1978) 1.06
Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1. J Exp Med (1988) 1.05
Evidence for gene conversion among immunoglobulin heavy chain variable region genes. J Exp Med (1984) 1.05
In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc Natl Acad Sci U S A (1993) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Functional antibody lacking a variable-region disulfide bridge. Proc Natl Acad Sci U S A (1986) 1.04
Genetic basis for expression of the idiotypic network. One unique Ig VH germline gene accounts for the major family of Ab1 and Ab3 (Ab1') antibodies of the GAT system. J Exp Med (1986) 1.04
T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proc Natl Acad Sci U S A (1995) 1.04
Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis (2001) 1.04
Inverse correlation between steady-state RNA and cell surface T cell receptor levels. FASEB J (1990) 1.02
Characterization of the developmentally regulated Bacillus subtilis glucose dehydrogenase gene. J Bacteriol (1986) 1.01
Allelic forms of the immunoglobulin heavy chain variable region. J Immunol (1980) 1.00
Structural, functional, and idiotypic characteristics of a phosphorylcholine-binding IgA myeloma protein of C57BL/ka allotype. J Exp Med (1975) 0.99
Cross-reactive idiotypic determinants on murine anti-(T,G)-A--L antibodies. J Immunol (1978) 0.99
kappa-Chain restriction in anti-galactan antibodies. J Immunol (1982) 0.98
Intravesical foreign body and vesicovaginal fistula: a rare complication of a neglected pessary. Int Urogynecol J Pelvic Floor Dysfunct (1999) 0.97
TAF(II)250-independent transcription can be conferred on a TAF(II)250-dependent basal promoter by upstream activators. J Biol Chem (2000) 0.97
VL-VH expression by monoclonal antibodies recognizing avian lysozyme. J Immunol (1984) 0.96
An IgM Waldenström with specificity against phosphorylcholine. Biochemistry (1975) 0.95
HIV Tat represses transcription through Sp1-like elements in the basal promoter. Immunity (1995) 0.94
Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state. Ann N Y Acad Sci (1989) 0.94
Contribution of the VK4 light chain to antibody specificity for lysozyme and beta (1,6)D-galactan. Mol Immunol (1986) 0.94
Characterization of a new subfamily of class I genes in the H-2 complex of the mouse. Immunogenetics (1988) 0.93
Interaction and sequence diversity among T15 VH genes in CBA/J mice. J Exp Med (1988) 0.93
Identity and properties of the chloride effector binding site in hog pancreatic alpha-amylase. Biochemistry (1976) 0.93